Daniel W. Bowles

11.0k citations
118 papers · 3.2k · 2 hit papers · h-index 32

Impact in

Papers in

    • Lung Cancer Research Studies 7
    • Cancer-related Molecular Pathways 7
    • PI3K/AKT/mTOR signaling in cancer 8
    • Hedgehog Signaling Pathway Studies 7

Daniel W. Bowles

113 papers receiving 3.2k citations

Daniel W. Bowles's Hit Papers

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial 2022 · 154 citations
1540+2+5Years since publication100200300

Peers

Daniel W. Bowles
Comparison fields: 5 of 106
  • Otorhinolaryngology 367
  • Oncology 1.1k
  • Endocrinology, Diabetes and Metabolism 599
  • Pulmonary and Respiratory Medicine 650
  • Cancer Research 290
Replace Jill Gilbert with:
Jill Gilbert United States
Victoria Villaflor United States
Tawee Tanvetyanon United States
Mark Zafereo United States
Guy Andry Belgium
Alexandre Bozec France
Stuart J. Wong United States
Joseph Curry United States
Sjoukje F. Oosting Netherlands
Stephen C.K. Law China
Daniel W. Bowles relative to Jill Gilbert United States Jill Gilbert's profile →
Citations per field
00.5×1.5×2.0×
Jill Gilbert · 1×
Citations per year

Countries citing papers authored by Daniel W. Bowles

Since Specialization
Citations

This map shows the geographic impact of Daniel W. Bowles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel W. Bowles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel W. Bowles more than expected).

Fields of papers citing papers by Daniel W. Bowles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel W. Bowles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel W. Bowles. The network helps show where Daniel W. Bowles may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel W. Bowles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel W. Bowles Line = papers co-authored together Daniel W. Bowles links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers
Hit paper breakdown →
2018384
2 2021162
3
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
Hit paper breakdown →
2022154
4 2018144
5 2012134
6 2019110
7 201692
8 201785
9 202082
10 201679
11 201872
12 201672
13 201770
14 201566
15 201755
16 201454
17 201353
18 201152
19 201149
20 201846

About Daniel W. Bowles

Daniel W. Bowles is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism, having authored 118 papers that have together received 3.2k indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (20 papers), Salivary Gland Tumors Diagnosis and Treatment (18 papers), Lung Cancer Treatments and Mutations (17 papers), Head and Neck Cancer Studies (15 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Lung Cancer Research Studies (7 papers), Cancer-related Molecular Pathways (7 papers) and Hedgehog Signaling Pathway Studies (7 papers). The work is most often cited by research in Otorhinolaryngology (367 citations), Oncology (1.1k citations), Endocrinology, Diabetes and Metabolism (599 citations), Pulmonary and Respiratory Medicine (650 citations) and Cancer Research (290 citations). Daniel W. Bowles has collaborated with scholars based in United States, Spain and South Korea. Frequent co-authors include Jessica D. McDermott, Antonio Jimeno, Sana D. Karam, David Raben, Jeffrey S. Ross, Laurie M. Gay, Aik Choon Tan, Nikita Pozdeyev, Rebecca E. Schweppe and Bernard L. Jones. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Drugs of today, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact